Takizawa, Tsubasa
Ihara, Keiko
Unekawa, Miyuki
Iba, Chisato
Kagawa, Shizuko
Watanabe, Narumi
Nakayama, Shingo
Sakurai, Kaori
Miyazaki, Naoki
Ishida, Noriyuki
Takemura, Ryo
Shibata, Mamoru
Izawa, Yoshikane
Chubachi, Shotaro
Fukunaga, Koichi
Nakahara, Jin
Article History
Received: 28 May 2024
Accepted: 11 September 2024
First Online: 2 October 2024
Declarations
:
: All experimental procedures were approved by the Keio University Institutional Animal Care and Use Committee (authorizations #A2022-257 and A2021-006). All procedures were performed in accordance with university guidelines and Animal Research: Reporting of In Vivo Experiments (ARRIVE) reporting guidelines for the care and use of laboratory animals.
: Not applicable.
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: TT is a consultant/advisor and/or serves on an advisory board for Eli Lilly, Otsuka, Amgen, Pfizer, and Teijin and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, Amgen, Kowa, Kyowa Kirin, Eisai, UCB Japan, Takeda, and Santen Pharmaceutical and grant/funding from Eli Lilly, Pfizer, and Tsumura outside the submitted work. JN has received honoraria and research scholarships from Amgen, Novartis, and Daiichi Sankyo.